x

Política de cookies

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso.

Más información
Permissions Requests - Help - - Sign up - Phone number 902 888 740
Search

Metrics

  • Impact Factor: 1.439 (2016)
  • CiteScore 2017: 1.24
    Read more
  • SCImago Journal Rank (SJR):0,504
  • Source Normalized Impact per Paper (SNIP):0,791

© Thomson Reuters, Journal Citation Reports, 2017

Indexed in:

Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME Cancerlit, Bibliomed, CabHealth, Scisearch, HealthStar, Scopus, Prous, Science Intergews, Science Citation Index Expanded.
Contents of previous issue | Contents of following issue

Vol. 45 .S1. December 2017
Special Issue: Sagunto's Second Scientific Meeting on Immunotherapy. Regulation and Current Situation.

First round table

Reviews

Proposals for harmonization of allergens regulation in the European Union

M. Timón
Allergol Immunopathol (Madr) 2017;45 Supl 1:1-3

Quality requirements for allergen extracts and allergoids for allergen immunotherapy

J. Zimmer, A. Bonertz, S. Vieths
Allergol Immunopathol (Madr) 2017;45 Supl 1:4-11

Predictive biomarkers in allergen specific immunotherapy

D. Barber, M.M. Escribese
Allergol Immunopathol (Madr) 2017;45 Supl 1:12-4

Point of View

Requirements of a new allergen regulation

Cristina Rivas-Juesas, Joan Tomás Bartra, Ana M. Purroy Tabar
Allergol Immunopathol (Madr) 2017;45 Supl 1:15-6

Second round table

Reviews

Worldwide allergen immunotherapy guidelines: Evidence and experience-based

D.E.S. Larenas-Linnemann
Allergol Immunopathol (Madr) 2017;45 Supl 1:17-22

Point of View

Debates in allergy, regarding the symposium on: “Position Statements and Therapeutic Guidelines”

P. Rodríguez del Río, A. Cisteró-Bahima, R. van Ree
Allergol Immunopathol (Madr) 2017;45 Supl 1:23-4

Third round table

Reviews

Epicutaneous immunotherapy

S. Scheurer, M. Toda
Allergol Immunopathol (Madr) 2017;45 Supl 1:25-9

Tablet-based sublingual immunotherapy for respiratory allergy

L. Prieto
Allergol Immunopathol (Madr) 2017;45 Supl 1:30-5

The future of immunotherapy with individual allergens: Immunotherapy with fungi

F. Pineda
Allergol Immunopathol (Madr) 2017;45 Supl 1:36-8

Point of view

New routes of allergen immunotherapy

C.R. Juesas, C.M. Aguilar, S. Vieths
Allergol Immunopathol (Madr) 2017;45 Supl 1:39-40

Fourth round table

Reviews

Biologics in chronic urticaria

M. Ferrer, R. Madamba
Allergol Immunopathol (Madr) 2017;45 Supl 1:41-4

Biologics in the treatment of severe asthma

S. Quirce, E. Phillips-Angles, J. Domínguez-Ortega, P. Barranco
Allergol Immunopathol (Madr) 2017;45 Supl 1:45-9

New insight into cancer immunotherapy

M.M. Escribese, D. Barber
Allergol Immunopathol (Madr) 2017;45 Supl 1:50-5

Point of View

Non-allergenic immunotherapy

E. Ibáñez Echevarría, J. Bartra Tomás, D. Hernández Fernández de Rojas
Allergol Immunopathol (Madr) 2017;45 Supl 1:56-8